Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IM Cannabis Corp. IMCC

Healthcare  —  Drug Manufacturers Specialty & Generic
2.84 (0.34) (10.69%) as of 25 Sep
Market cap
$2.0M
P/E
0.0×
Cash Flow Champion (3y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

IM Cannabis Corp. (IMCC) Business Profile

Updated before January 2025

Company Overview

IM Cannabis Corp. (IMCC) is a leading international medical cannabis company with operations spanning across Israel, Germany, and Canada. Founded in 2010, the company has established itself as a pioneer in the medical cannabis industry, leveraging its expertise to provide high-quality cannabis products to patients and consumers worldwide. IMCC is headquartered in Israel, a country known for its advanced cannabis research and development. The company is led by a team of seasoned professionals, including Oren Shuster, the CEO and co-founder, who has been instrumental in driving the company’s growth and innovation. IMCC’s leadership team combines extensive experience in the cannabis, pharmaceutical, and healthcare industries, ensuring a strategic and forward-thinking approach to its operations.

Core Business Segments

IM Cannabis Corp. operates across several core business segments, each designed to cater to the diverse needs of its customers. These segments include:

Medical Cannabis Products

IMCC specializes in the production and distribution of premium medical cannabis products. The company offers a wide range of strains and formulations tailored to address various medical conditions, such as chronic pain, anxiety, and sleep disorders. Its product portfolio includes dried flower, oils, capsules, and other cannabis-based medical solutions.

Recreational Cannabis

In addition to its medical offerings, IMCC has a strong presence in the recreational cannabis market, particularly in Canada. The company provides high-quality recreational cannabis products, including pre-rolls, edibles, and concentrates, catering to adult consumers seeking premium cannabis experiences.

Distribution and Retail

IMCC operates a robust distribution network and retail presence, ensuring its products are accessible to customers in key markets. In Israel, the company has established partnerships with pharmacies and healthcare providers, while in Canada, it operates through licensed retail outlets and online platforms.

Research and Development

IMCC is committed to advancing cannabis research and development. The company collaborates with leading academic institutions and research organizations to develop innovative cannabis-based therapies and products. This focus on R&D enables IMCC to stay at the forefront of the industry and meet the evolving needs of its customers.

Business Model

IM Cannabis Corp. employs a vertically integrated business model, which allows it to control every aspect of the cannabis supply chain, from cultivation and production to distribution and retail. This approach ensures the highest quality standards and enables the company to maintain competitive pricing. IMCC generates revenue through the sale of its medical and recreational cannabis products, as well as through licensing agreements and partnerships. By leveraging its expertise in cultivation, manufacturing, and distribution, IMCC has established a sustainable and scalable business model that supports long-term growth.

Strategic Direction

IMCC is focused on expanding its global footprint and enhancing its product offerings to meet the growing demand for cannabis products. The company’s strategic priorities include:

  • Market Expansion: IMCC aims to strengthen its presence in existing markets, such as Israel, Germany, and Canada, while exploring opportunities in emerging markets with favorable cannabis regulations.
  • Product Innovation: The company is dedicated to developing new and innovative cannabis products, including advanced formulations and delivery methods, to address unmet medical needs and consumer preferences.
  • Sustainability: IMCC is committed to sustainable practices across its operations, including environmentally friendly cultivation methods and responsible sourcing of raw materials.
  • Strategic Partnerships: The company seeks to collaborate with industry leaders, research institutions, and healthcare providers to drive innovation and expand its market reach.

Competitive Landscape

IM Cannabis Corp. operates in a highly competitive industry, facing competition from both established players and emerging companies. Key competitors include:

  • Tilray Brands Inc.: A global leader in cannabis research, cultivation, and distribution, with a strong presence in medical and recreational markets.
  • Aurora Cannabis Inc.: A Canadian company specializing in the production and distribution of medical and recreational cannabis products.
  • Canopy Growth Corporation: A major player in the cannabis industry, offering a diverse portfolio of products and brands.
  • Cronos Group Inc.: A global cannabinoid company focused on advancing cannabis research and innovation.

IMCC differentiates itself through its focus on premium quality, innovative products, and a strong presence in key international markets.

Risk Factors

Like any business, IM Cannabis Corp. faces several risks that could impact its operations and financial performance. Key risk factors include:

  • Regulatory Challenges: The cannabis industry is subject to complex and evolving regulations, which could affect IMCC’s ability to operate in certain markets.
  • Market Dependence: The company’s revenue is heavily reliant on the sale of cannabis products, making it vulnerable to fluctuations in demand and pricing.
  • Supply Chain Disruptions: Disruptions in the supply chain, such as shortages of raw materials or transportation issues, could impact IMCC’s ability to meet customer demand.
  • Competition: Intense competition in the cannabis industry could pressure pricing and market share.
  • Economic Conditions: Economic downturns or changes in consumer spending habits could affect demand for cannabis products.

Recent Developments

IM Cannabis Corp. has made significant strides in recent years, including:

  • Product Launches: The company has introduced new medical and recreational cannabis products, expanding its portfolio to meet diverse customer needs.
  • Strategic Acquisitions: IMCC has acquired several companies to strengthen its market position and enhance its capabilities in cultivation, production, and distribution.
  • Global Expansion: The company has entered new markets and established partnerships to drive growth and increase its international presence.
  • Technological Advancements: IMCC has invested in advanced cultivation and manufacturing technologies to improve efficiency and product quality.

Investment Considerations

Investors considering IM Cannabis Corp. should weigh the following strengths and risks:

Strengths

  • Strong presence in key international markets, including Israel, Germany, and Canada.
  • Vertically integrated business model ensures quality control and cost efficiency.
  • Commitment to innovation and R&D supports long-term growth.
  • Experienced leadership team with a proven track record.

Risks

  • Regulatory and legal challenges in the cannabis industry.
  • Dependence on cannabis product sales for revenue.
  • Intense competition from established and emerging players.
  • Potential supply chain disruptions and economic uncertainties.

Conclusion

IM Cannabis Corp. is a leading player in the global cannabis industry, with a strong focus on quality, innovation, and sustainability. The company’s vertically integrated business model and strategic initiatives position it for long-term growth and success. While the cannabis industry presents unique challenges, IMCC’s commitment to excellence and its experienced leadership team make it a compelling choice for investors seeking exposure to this dynamic and rapidly evolving market.